Daniel Zamanillo-Castanedo,Enrique Portillo-Salido
申请号：
US15104384
公开号：
US09931346B2
申请日:
2014.12.16
申请国别(地区):
US
年份:
2018
代理人:
摘要：
The invention refers to a synergistic combination comprising a Sigma ligand of general formula (I), and a Serotonin-Norepinephrine Reuptake Inhibitor (SNRI), a medicament comprising said active substance combination, and the use of said active substance combination for the manufacture of a medicament, particularly for the prophylaxis and/or treatment of pain.
